Phase I Clinical Study of ZYAN1, A Novel Prolyl-Hydroxylase (PHD) Inhibitor to Evaluate the Safety, Tolerability, and Pharmacokinetics Following Oral Administration in Healthy Volunteers

Clinical Pharmacokinetics
Kevinkumar A KansagraKinjal Barot

Abstract

This phase I study of ZYAN1 was conducted to evaluate the safety, tolerability, and pharmacokinetics following oral administration in healthy volunteers. The study was a randomized, double-blind, placebo-controlled phase I study carried out in two parts in addition to a third part involving an open-label study to evaluate the food/sex effect. A total of 100 subjects were enrolled into the study as follows: part I-single-dose study with ZYAN1 10, 25, 50, 100, 150, 200, and 300 mg (n = 56); part II-multiple-dose study with every other day dosing of ZYAN1 100, 150, 200, and 300 mg (n = 32); and part III-sex and food effect study with ZYAN1 150 mg (n = 12; open-label). ZYAN1 was well-tolerated after single and multiple oral ascending doses. No drug-related serious adverse events were reported. Following a single ascending dose of ZYAN1, the maximum concentration (C max) ranged from 566.47 ± 163.03 to 17,858.33 ± 2899.19 ng/mL and the median time to C max (t max) was approximately 2.5 h for the studied 30-fold oral doses of ZYAN1. Regardless of single or multiple doses, mean C max and area under the concentration-time curve from time zero to time t (AUC t ) values generally showed a dose-proportional increase. The mean elimination h...Continue Reading

References

Jan 20, 1995·The Journal of Biological Chemistry·G L Wang, G L Semenza
Jun 29, 2002·Journal of the American Society of Nephrology : JASN·Christian RosenbergerKai-Uwe Eckardt
Aug 19, 2006·Nature Reviews. Drug Discovery·Irena Melnikova
Jun 6, 2008·Journal of the American Society of Nephrology : JASN·Bruce S SpinowitzBrian J G Pereira
Nov 13, 2009·Acta Haematologica·Neeraj Agarwal, Josef T Prchal
May 7, 2010·American Journal of Physiology. Renal Physiology·Volker H Haase
Sep 2, 2010·Cell Stem Cell·Keiyo TakuboToshio Suda
Dec 1, 2010·Journal of the American Society of Nephrology : JASN·Wanja M BernhardtKai-Uwe Eckardt
Feb 26, 2011·The Biochemical Journal·Jian Wang, Kostas Pantopoulos
Mar 17, 2011·Expert Opinion on Investigational Drugs·Eugene Muchnik, Joshua Kaplan
Aug 5, 2011·Lancet·Yarlini BalarajanS V Subramanian
Feb 7, 2012·Biochimica Et Biophysica Acta·Tomas Ganz, Elizabeta Nemeth
Mar 15, 2012·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·Saravanan S Karuppagounder, Rajiv R Ratan
Jan 8, 2013·Blood Reviews·Volker H Haase
Dec 9, 2010·ACS Medicinal Chemistry Letters·Mark D RosenMichael H Rabinowitz
Jul 30, 2014·Hematology/oncology Clinics of North America·Elizabeta Nemeth, Tomas Ganz
Aug 5, 2015·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Anatole BesarabThomas B Neff
Dec 15, 2015·Nature Reviews. Nephrology·Patrick H Maxwell, Kai-Uwe Eckardt

❮ Previous
Next ❯

Citations

Oct 31, 2020·Advances in Therapy·Ramy M HannaKamyar Kalantar-Zadeh
May 2, 2018·Journal of Medicinal Chemistry·Amit A JoharapurkarMukul R Jain

❮ Previous
Next ❯

Methods Mentioned

BETA
ubiquitination

Software Mentioned

Excel
WinNonlin
MedDRA
SAS

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.